Recent health news highlights various developments, including EssilorLuxottica's FDA clearance for Nuance audio glasses, WHO ...

Arvinas Inc. (NASDAQ:ARVN), a biotechnology company specializing in protein degradation therapeutics, stands at a critical juncture as it approaches the release of pivotal clinical trial data.

Since the first, seminal randomised controlled trial (RCT) in inflammatory bowel disease (IBD) in 1955,1 the central tenets ...

Modern structures are being adapted for reuse, with office-to-apartment conversions becoming more and more popular across the ...

The CEO said last month that the drugmaker had cut costs, revamped its sales operation, and made other big fixes.

Shares of Pfizer Inc. PFE slipped 1.21% to $26.20 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.76% to 5,994.57 and Dow ...

LANSING, MI — Pharmaceutical giant Pfizer has agreed to pay $59.7 million plus interest to settle bribery allegations against ...

Recent health news includes EssilorLuxottica's new FDA-approved Nuance audio glasses, Baxter's CEO José Almeida retiring, Pfizer facing challenges with COVID-related revenue, WHO budget cuts amid U.S ...

Pfizer (PFE) is set to announce Q4 earnings, with analysts expecting a $0.46 profit per share and $17.26B revenue.

California Attorney General Bonta announced a settlement against Pfizer (PFE)-owned Biohaven Pharmaceutical “for submitting false claims to the ...

Michigan has joined the U.S. Department of Justice, 37 other states and Puerto Rico in settling kickback allegations against a Pfizer, Inc. subsidiary. Pfizer has agreed to ...

Merck and Pfizer are heading into fourth quarter earnings with different technical setups, leaving investors unsure of which ...